Publications by authors named "N Milazzo"
Article Synopsis
- The study aimed to explore treatment strategies for tandem occlusions (TOs) during emergent carotid stenting in Italy, highlighting uncertainties in the best approach despite benefits from mechanical thrombectomy.
- A survey of 66 centers yielded a response rate of 84.8%, revealing that most prefer a retrograde approach with a closed-cell stent and single antiplatelet therapy during deployment.
- The findings indicate that practices for managing TOs are inconsistent across the Italian neurovascular community, emphasizing the need for more evidence to establish a standardized treatment protocol.
Article Synopsis
- Spontaneous occlusion of brain arteriovenous malformations (bAVMs) is rare, especially in unruptured cases, with factors like single-venous drainage and small nidus size potentially contributing.
- A case study describes an unruptured left-sided bAVM in a middle-aged male with a long history of refractory epilepsy, highlighting its spontaneous thrombosis without any signs of bleeding.
- The report underscores the distinction between occlusion caused by rupture and true spontaneous thrombosis in bAVMs.
Introduction: Energy drinks are an increasingly utilized beverage and are gaining popularity in recent years. The U.S.
View Article and Find Full Text PDFWe report polymer-promoted cooperative catalysis of Cu for oxygen activation. A series of random copolymers containing dipicolylamine as binding motifs are designed to coordinate type-3 Cu sites. The Cu-copolymers show a 6-8-fold activity enhancement, compared to the molecular complex of Cu with an identical coordination site.
View Article and Find Full Text PDFBackground: Outcomes of tailoring statin-type based on solute carrier organic anion transporterfamily member 1B1 ( SLCO1B1)pharmacogenetic toxicity information on patient, provider, and pharmacological outcomes are unknown.
Methods: The trial randomized 159 patients not taking statins because of prior statin myalgia 1:1 to receiving SLCO1B1 GIST (Genotype Informed Statin Therapy) versus usual care (UC) and followed for up to 8 months. The UC arm received their SLCO1B1 results post-trial.